The devastating wildfires across the Los Angeles area have put additional pressure on California’s already-strained insurance market, as well as the FAIR Plan - the “provider of last resort.” ...

Sanofi is trailing behind GSK and Pfizer when it comes to vaccines for respiratory syncytial virus (RSV), but it still thinks it can be the top player in the market with a combination of its ...

The patents in contention are numbers 3,109,258, 2,222,710 and 3,178,490, all awarded by the European Patent Office and covering recombinant RSV antigens and compositions and methods for making them.

The National Academies of Sciences, Engineering, and Medicine are private, nonprofit institutions that provide expert advice on some of the most pressing challenges facing the nation and world. Our ...

This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long ...

This narrowing results from swelling caused by a virus. The respiratory syncytial virus (RSV) causes most bronchiolitis. RSV occurs in epidemics almost every winter. People do not develop life-long ...

Monday – Thursday, noon – 1 p.m. Rebroadcast 7 p.m. – 8 p.m.

SAN FRANCISCO — New data suggest that lenacapavir delivered just once per year could be as effective for HIV prevention as the twice-yearly injections already under review by the FDA.

Javascript must be enabled to use this site. Please enable Javascript in your browser and try again. If you think you’ve been targeted by a scam, get information ...

CTV National News: Finding the origin of COVID-19 Allison Bamford has the latest on the new findings from a team of scientists, including a virologist from Sask., into the origins of COVID.